SM
GCTK icon

Sabby Management’s GlucoTrack GCTK Stock Holding History

Sabby Management’s Portfolio GCTK Stock Details GCTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-102
Closed -$204K – 48
2024
Q1 		$204K Buy
102
+31
+44% +$48.6K 0.12% 24
2023
Q4 		$112K Sell
71
-263
-79% -$349K 0.11% 34
2023
Q3 		$526K Sell
334
-5
-1% -$8.98K 0.39% 14
2023
Q2 		$702K Buy
+339
New +$1.22M 0.57% 14

Other funds holding GCTK

AF
Alerus Financial Grand Forks, North Dakota $2.02B AUM 26.03% 1-Year Est. Return
Cetera Investment Advisers
Cetera Investment Advisers Schaumburg, Illinois $94B AUM 20.14% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Sabby Management's GCTK Position: Q2 2024 in Review

Sabby Management sold out of GlucoTrack (GCTK) in Q2 2024, closing a stake of 102 shares — an estimated $204K sold.

Sabby Management first reported a position in GCTK in Q2 2023 and held it in 4 quarters. The position peaked at $702K in Q2 2023. 3 funds tracked by Wall St. Rank hold GCTK as of Q2 2024.

  • Sabby Management reported no remaining GlucoTrack position as of Q2 2024 after selling out during the quarter.
  • Sabby Management sold 102 GlucoTrack shares in Q2 2024, an estimated $204K.
  • Sabby Management first reported a position in GlucoTrack in Q2 2023 and held it in 4 quarters.
  • Sabby Management's GlucoTrack position peaked at $702K in Q2 2023.
  • 3 funds tracked by Wall St. Rank held GlucoTrack as of Q2 2024.

Based on Sabby Management's 13F filing for Q2 2024, filed 14 Aug 2024.